...
首页> 外文期刊>American Journal of Physiology >Alpha1-adrenergic activation of myocardial Na-K-2Cl cotransport involving mitogen-activated protein kinase.
【24h】

Alpha1-adrenergic activation of myocardial Na-K-2Cl cotransport involving mitogen-activated protein kinase.

机译:涉及促分裂原活化蛋白激酶的心肌Na-K-2Cl共转运的Alpha1-肾上腺素能激活。

获取原文
获取原文并翻译 | 示例

摘要

The translocation mechanisms involved in the alpha1-adrenoceptor-stimulated efflux of the potassium analog 86Rb+ were studied in isolated rat hearts. Phenylephrine (in the presence of a beta-blocker) increased the efflux of 86Rb+ and 42K+, and the Na-K-2Cl (or K-Cl) cotransport inhibitor bumetanide reduced the response by 42 +/- 11%. Furosemide inhibited the response with a lower potency than that of bumetanide. The bumetanide-insensitive efflux was largely sensitive to the K+ channel inhibitor 4-aminopyridine. Inhibitors of the Na+/H+ exchanger or the Na+-K+ pump had no effect on the increased 86Rb+ efflux. The activation of the Na-K-2Cl cotransporter was dependent on the extracellular signal-regulated kinase (ERK) subgroup of the mitogen-activated protein (MAP) kinase family. Phenylephrine stimulation increased ERK activity 3.4-fold. PD-98059, an inhibitor of the ERK cascade, reduced both the increased 86Rb+ efflux and ERK activity. Specific inhibitors of protein kinase C and Ca2+/calmodulin-dependent kinase II had no effect. In conclusion, alpha1-adrenoceptor stimulation increases 86Rb+ efflux from the rat heart via K+ channels and a Na-K-2Cl cotransporter. Activation of the Na-K-2Cl cotransporter is apparently dependent on the MAP kinase pathway.
机译:在离体大鼠心脏中研究了α1-肾上腺素受体刺激钾类似物86Rb +流出的转运机制。苯肾上腺素(在存在β受体阻滞剂的情况下)增加了86Rb +和42K +的流出,而Na-K-2Cl(或K-Cl)共转运抑制剂布美他尼使反应降低42 +/- 11%。速尿比布美他尼抑制反应的效力低。对布美他尼不敏感的外排对K +通道抑制剂4-氨基吡啶很敏感。 Na + / H +交换剂或Na + -K +泵的抑制剂对增加的86Rb +外排没有影响。 Na-K-2Cl共转运蛋白的激活取决于有丝分裂原活化蛋白(MAP)激酶家族的细胞外信号调节激酶(ERK)亚组。苯肾上腺素刺激使ERK活性增加了3.4倍。 PD-98059是ERK级联的抑制剂,可降低增加的86Rb +外排和ERK活性。蛋白激酶C和Ca2 + /钙调蛋白依赖性激酶II的特异性抑制剂无效。总之,α1-肾上腺素受体刺激通过K +通道和Na-K-2Cl协同转运蛋白增加了大鼠心脏的86Rb +外排。 Na-K-2Cl共转运蛋白的激活显然取决于MAP激酶途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号